Medicine and Dentistry
Patient
100%
Mortality
42%
Pneumonia
38%
Community-Acquired Pneumonia
24%
Therapeutic Procedure
21%
Diagnosis
21%
Infection
19%
Inpatient
18%
Pathogen
18%
Combination Therapy
16%
Intensive Care Unit
16%
Antibiotics
14%
Coughing
12%
Diseases
11%
Adult
11%
Ventilator-Associated Pneumonia
11%
Artificial Respiration
11%
Hospital
10%
Chronic Obstructive Pulmonary Disease
10%
Lung
10%
Association
9%
Complication
9%
Macrolide
8%
Pneumococcal Pneumonia
7%
Development
7%
Prevalence
7%
Bronchiectasis
7%
Morbidity
7%
Corticosteroid
7%
Systematic Review
7%
Etiology
7%
Sepsis
6%
Odds Ratio
6%
Analysis
6%
Age
6%
Antibiotic Therapy
6%
Pseudomonas aeruginosa
6%
Methicillin Resistant Staphylococcus Aureus
6%
Necroptosis
5%
Incidence
5%
Veterans Affairs
5%
Immunocompromised Patient
5%
Serositis
5%
COVID-19
5%
Intensive Care Medicine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Community Acquired Pneumonia
73%
Pneumonia
51%
Mortality
49%
Corticosteroid
17%
Ventilator Associated Pneumonia
15%
Antibiotic Agent
14%
Infectious Agent
14%
Chronic Obstructive Lung Disease
14%
Infection
13%
Diseases
10%
Macrolide
10%
Prevalence
10%
Antibiotics
9%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Morbidity
7%
Drug
7%
Pseudomonas aeruginosa
7%
Bronchiectasis
7%
Antiinfective Agent
6%
Sepsis
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Survival
6%
Incidence
6%
Etiology
6%
Cohort Study
6%
Quinolone Derivative
6%
Antibiotic Therapy
6%
Complication
6%
Hospital Acquired Pneumonia
6%
Mouse
5%
Methicillin-Resistant Staphylococcus Aureus
5%
Streptococcus Pneumoniae
5%
Coughing
5%
Influenza
5%
Procalcitonin
5%
Cystic Fibrosis
5%
Nursing and Health Professions
Patient
43%
Community Acquired Pneumonia
28%
Mortality
18%
Inpatient
13%
Intensive Care Unit
12%
Ventilator-Associated Pneumonia
11%
Infection
9%
Pneumonia
7%
Hospital
6%
Diseases
6%
Sepsis
6%
Diagnosis
6%
Practice Guideline
5%
